Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 456 of 1,261

  1. US 10500175

    Compositions and methods for the treatment of cancer

    KoDiscovery, LLC · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  2. US 10500177

    Glutarate compounds for treating ischemia-reperfusion injuries

    The Regents of the University of California · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  3. US 10500156

    Multi-compartmental macrophage delivery

    Northwestern University · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  4. US 10501816

    Compositions and methods for detecting human pegivirus 2 (HPgV-2)

    The Regents of the University of California · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  5. US 10501800

    Breast cancer prognosis

    Regents of the University of Minnesota · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  6. US 10501742

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  7. US 10501801

    Identification of tumor-protective epitopes for the treatment of cancers

    UNIVERSITY OF CONNECTICUT · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  8. US 10501740

    Compositions and methods for inhibiting expression of factor V

    Alnylam Pharmaceuticals, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  9. US 10501575

    Biomimetic fluoroscopic films

    The Board of Regents of the University of Texas System · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  10. US 10501538

    Anti-LILRB antibodies and their use in detecting and treating cancer

    The Board of Regents of the University of Texas System · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  11. US 10501528

    Immunoglobulin single variable domain antibody against RSV prefusion F protein

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  12. US 10494402

    Peptides that stimulate subcutaneous adipogenesis

    The Regents of the University of California · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  13. US 10494401

    LLP2A-bisphosphonate conjugates for osteoporosis treatment

    The Regents of the University of California · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  14. US 10493065

    Formulations and methods of manufacturing formulations for use in colonic evacuation

    RedHill Biopharma Ltd. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  15. US 10494405

    Methods and compositions for the treatment of arthritis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  16. US 10494440

    Use of semaphorin-4D binding molecules to promote neurogenesis following stroke

    VACCINEX, INC. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  17. US 10494619

    High isomerohydrolase activity mutants of human RPE65

    The Board of Regents of the University of Oklahoma · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  18. US 10493098

    Mesoporous silica-coated nanoparticles

    Regents of the University of Minnesota · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  19. US 10493103

    Peroxide formulations and methods and applicators for using the same

    Aclaris Therapeutics, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  20. US 10493066

    Fumarate analogs and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  21. US 10494347

    Processes for the preparation of uracil derivatives

    Neurocrine Biosciences, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  22. US 10492518

    Blood lipid-lowering composition, method for preparing the same and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  23. US 10493069

    Methods of treating behavioral syndromes using pipradrol

    OVID THERAPEUTICS INC. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  24. US 10493092

    Antisense compounds

    Ionis Pharmaceuticals, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.